Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2002-01-28
2004-06-22
Priebe, Scott D. (Department: 1632)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S029000, C435S325000, C435S352000, C435S357000
Reexamination Certificate
active
06753146
ABSTRACT:
BACKGROUND OF THE INVENTION
Chronic sun exposure eventuates in wrinkling, sagging, pigmentary alterations, and skin cancers which are characteristic of sun-damaged skin, and collectively referred to as photoaging (Kligman, A. M. JAMA 210:2377-2380, 1969; Gilchrest, B. A. J. Am. Acad. Dermatol. 21:610-613, 1989). The major histopathologic alteration in the dermis of photoaged skin underlying the wrinkling, sagging and yellow discoloration characterizing photoaged skin is the accumulation of large amounts of abnormal elastic material, termed solar elastosis replacing the normally collagen-rich dermis (Mera et al. Br. J. Dermatol. 117:21-27, 1987; Bernstein et al. J. Invest. Dermatol. 103:182-186, 1994). One of the primary events in the generation of solar elastosis is elastin promoter activation (Bernstein et al. J. Invest. Dermatol. 105, 269-273, 1995).
A transgenic mouse line expressing the human elastin promoter linked to a chloramphenicol acetyltransferase reporter gene (CAT) has been developed which models cutaneous photoaging in an in vivo and in vitro system (Bernstein et al. J. Invest. Dermatol. 105, 269-273, 1995). Although phenotypically normal, the cells in these mice possess the human elastin promoter/CAT construct, allowing elastin promoter activity to be measured in response to stimuli such as ultraviolet radiation (UV). These mice, and fibroblasts cultures derived from their skin, have been demonstrated to provide a rapid and sensitive means of identifying compounds capable of inhibiting cutaneous photodamage (Bernstein et al. J. Invest. Dermatol. 105, 269-273, 1995; Bernstein et al. Photochem. Photobiol. 64:369-74, 1996; Bernstein et al. J. Am. Acad. Dermatol. 37:725-729, 1997).
Among the various mechanisms by which UV damages skin is the generation of reactive oxygen species (Miyachi, Y. J. Dermatol. Sci. 9:79-86, 1995). Reactive oxygen species may form immediately as a result of UV exposure, or result from the inflammatory response which often follows UV-induced injury. Although the erythema of a sunburn is clinical evidence of damage from UV, an inflammatory infiltrate may be evident histopathologically even in the absence of erythema, and may result in continued exposure of the dermis to free radicals, days after the UV-induced damage has occurred (Kligman, A. M. JAMA 210:2377-2380, 1969; Lavker et al. J. Am. Acad. Dermatol. 32:53-62, 1995). The role of free radicals in cutaneous photodamage has been well documented (Ranadive, N. S. and Menon, I. A. Pathol. Immunopathol. Res. 5:118-139, 1986; Miyachi, Y and Imamura, S. Photodermatol. Photoimmunol. Photomed. 7:49-50 1990; Miyachi, Y. J. Dermatol. Sci. 9:79-86, 1995; and Peak et al. Photochem. Photobiol. 54:197-203, 1991). UV-induced free radical generation in skin has been demonstrated (Peak et al. Photochem. Photobiol. 54:197-203, 1991; and Norins, A. L. J. Invest. Dermatol. 39: 445-448, 1962). In addition, some enzymes which protect against oxidative damage, such as superoxide dismutase and catalase, are depleted after UV exposure (Pence, B. C. and Naylor, M. F. J. Invest. Dermatol. 95:213-216, 1990; Maeda et al. Photochem. Photobiol. 54:737-740, 1991; Shindo, Y and Hashimoto, T. J. Dermatol. Sci. 14:225-232, 1997), and antioxidants that scavenge free radicals have demonstrated protection against UV (DeRios et al. J. Invest. Dermatol. 70:123-125, 1975; and Bissett et al. J. Soc. Cosmet. Chem. 43:85-92, 1992). Investigators have recently demonstrated elastin mRNA production in response to free radicals generated using a xanthine and xanthine oxidase system in vitro, providing evidence for the role of oxidative stress in the generation of solar elastosis (Kawaguchi et al. Free Radical Biol. Med. 23:162-165, 1997).
It has now been demonstrated that reactive oxygen species stimulate elastin production at the promoter level in fibroblasts derived from a transgenic mouse model of cutaneous photoaging. Further, the ability of an agent known to protect against oxidative damage to inhibit stimulation of elastin production in this system has also been demonstrated. Accordingly, the present invention relates to an in vitro system and method for identifying agents capable of protecting against oxidative damage via a mouse fibroblast culture derived from a transgenic mouse capable of expressing human elastin promoter and a means for generating reactive oxygen species within the mouse fibroblast cultures.
SUMMARY OF THE INVENTION
An object of the present invention is to provide an in vitro system for identifying agents capable of inhibiting or preventing oxidative damage comprising a mouse fibroblast culture derived from a transgenic mouse capable of expressing human elastin promoter and a means for generating reactive oxygen species within the mouse fibroblast culture.
A method of identifying agents capable of inhibiting or preventing oxidative damage using this system is also provided.
DETAILED DESCRIPTION OF THE INVENTION
Oxidative damage may play a greater role in dermal, as compared to epidermal, damage from UV. Thus the generation of photoaging, clinically evident as wrinkling and sagging of skin, may result more from free radical-induced mechanisms than UV-induced skin cancers which originate in the epidermis. Evidence for this includes the greater sensitivity of fibroblasts to free radical-induced damage as compared to keratinocytes (Applegate, L. A. and Frenk, E. Photodermatol. Photoimmunol. Photomed. 11:95-101, 1995; Moysan et al. Photodermatol. Photoimmunol. Photomed. 11:192-197, 1995; Masaki, H. and Sakurai, H. J. Dermatol. Sci. 14:207-216, 1997), and the fact that circulating inflammatory cells which produce free radicals course through the dermis and less frequently invade the epidermis. Also the longer wavelengths of UV, which produce less direct DNA damage (Setlow, R. B. Science 153:379-386, 1966) but may exert their deleterious effects mainly through oxidative mechanisms, penetrate more deeply into skin, depositing much of their energy in the dermis. Thus, free radical mechanisms of damage may be the primary means by which UVA-induced photoaging takes place.
A number of effective sunscreens for blocking UVB are currently on the market, and increasing amounts of UVA protection are being incorporated into sunscreens to obtain higher sun protection factors. Further improvements are likely to result from incorporating effective free radical scavengers into currently available sunscreens. Accordingly, there is a need for a system of identifying agents which inhibit or prevent oxidative damage from the sun.
U.S. Pat. No. 5,648,061 discloses a transgenic mouse model which permits investigation of human elastin promoter activity in response to ultraviolet irradiation both in vivo by direct irradiation of mouse skin, and in vitro by irradiation of dermal fibroblasts grown from skin explants. It has now been demonstrated that generation of reactive oxygen species in these dermal fibroblasts via a hypoxanthine and xanthine-oxidase system results in a 6-fold increase in elastin promoter activity. Further, this increase can be eliminated by the addition of catalase, an enzyme known to protect against oxidative damage. Accordingly, incorporation of a means for generating reactive oxygen species such as a hypoxanthine and xanthine oxidase system within these mouse fibroblast cultures results in a sensitive system for evaluating agents which may prevent oxidative damage. Using this system agents which may protect against the oxidative damage resulting from UV exposure may be rapidly screened, and promising candidates identified for further study and eventual incorporation into sunscreens.
A series of experiments were performed with this new system.
In a first set of experiments, the optimum time span for incubation of fibroblasts, derived from the skin of transgenic mice, with a hypoxanthine and xanthine oxidase system was determined by exposing cells to a hypoxanthine and xanthine oxidase system for increasing amounts of time, and determining CAT activity as outlined in Example 3 after a 24 hour incubation. CAT activit
Bernstein Eric F.
Licata & Tyrrell P.C
Priebe Scott D.
LandOfFree
System and method for evaluating agents which prevent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for evaluating agents which prevent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for evaluating agents which prevent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3337161